Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/23849
Full metadata record
DC FieldValueLanguage
dc.contributor.author(Kali), S Mukhopadhyay-
dc.contributor.authorPoddar, M K-
dc.date.accessioned2013-11-20T05:32:34Z-
dc.date.available2013-11-20T05:32:34Z-
dc.date.issued2001-08-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/23849-
dc.description735-741en_US
dc.description.abstractLong- term administration of caffeine at a dose of 20 mg/kg /day p.o. suppressed the viability, oxygen consumption and [3H]-thymidine incorporation of Ehrlich ascites carcinoma (EAC) cells. Though no significant change in the levels of plasma and adrenal corticosterone as well as both total and reduced adrenal ascorbic acid were observed following longterm caffeine consumption, pretreatment of caffeine and continuation of its treatment in the course of development of EAC cells restored the EAC Cell-induced changes in both corticosterone and ascorbic acid levels to control values. These results, thus, suggest that caffeine may suppress the growth of EAC cells by modulating the adrenal ascorbate level as well as corticosterone status. en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.39(08) [August 2001]en_US
dc.titleCaffeine inhibits the development of Ehrlich ascites carcinoma cells in female miceen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.39(08) [August 2001]

Files in This Item:
File Description SizeFormat 
IJEB 39(8) 735-741.pdf1.65 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.